Shifting landscape of hemophilia therapy: Implications for current clinical laboratory coagulation assays
Author:
Affiliation:
1. Center for Hematology; Massachusetts General Hospital Cancer Center; Boston Massachusetts
2. Harvard Medical School; Boston Massachusetts
3. Boston Children's Hospital, Boston Hemophilia Center; Boston Massachusetts
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25153/fullpdf
Reference73 articles.
1. Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein;Peters;J Thromb Haemost.,2013
2. BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation;Turecek;Hamostaseologie.,2012
3. Pharmacokinetic drug evaluation of albutrepenonacog alfa (CSL654) for the treatment of hemophilia;Morfini;Expert Opin Drug Metab Toxicol.,2016
4. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B;Powell;N Engl J Med.,2013
5. Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B;Negrier;Blood.,2011
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A;Journal of Thrombosis and Haemostasis;2024-07
2. Consensus-Based Expert Recommendations on the Management of Hemophilia A in the Gulf Region;Acta Haematologica;2024-04-02
3. Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic‐guided dosing of replacement therapy in haemophilia A?;Haemophilia;2022-05-08
4. Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy;Clinical and Applied Thrombosis/Hemostasis;2022-01
5. Hemophilia A (Factor VIII Deficiency);Hematology/Oncology Clinics of North America;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3